Licensing opportunity
Researchers at the University & University Hospitals, Lausanne have discovered new DNA molecules that have insulator, or boundary, properties for use in the construction of vectors that allow controlled expression in gene therapy.
They say the discovery paves the way for better gene transfer systems with increased specificity, efficiency and safety.
Another aspect of the invention covers the treatment of patients diagnosed with genetic disease by administering such new vectors.
An International Patent has been applied for.
Additional information is available upon request, quoting reference IDF05/07.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
